INIS
patients
100%
pain
79%
hospitals
67%
drugs
67%
fractures
67%
comparative evaluations
51%
units
45%
muscles
45%
tissues
45%
swelling
45%
stability
33%
management
33%
clinical trials
33%
strains
33%
tumors
33%
control
33%
inflammation
33%
hands
33%
stabilization
33%
energy
33%
evaluation
33%
workers
33%
polyesters
33%
soils
33%
thermal power plants
33%
assessments
33%
environment
33%
pollution
33%
populations
33%
surgery
33%
sulfates
22%
chondroitin
22%
limbs
22%
glucosamine
22%
nmr imaging
22%
females
19%
restoration
19%
range
19%
values
18%
peaks
16%
flow rate
16%
water
16%
levels
16%
air
16%
age groups
16%
heavy metals
16%
india
15%
symptoms
15%
motion
14%
industry
12%
Medicine and Dentistry
Tertiary Care
67%
Nonsteroid Antiinflammatory Agent
67%
Orthopedics
53%
Neoplasm
50%
Magnetic Resonance Imaging
50%
Outpatient
39%
Lipoma
33%
Myoepithelioma
33%
Clavicle Fracture
33%
Osteoarthritis
33%
Calcaneus Fracture
33%
Limb
33%
Edema
33%
Paracetamol
22%
Patient Satisfaction
22%
Mixed Tumor
16%
Cytokeratin AE1
16%
Tumor Cell
16%
Sacroiliac Joint
16%
Stroma
16%
Immunoreactivity
16%
Chondrosarcoma
16%
Squamous Metaplasia
16%
Surgery
13%
Visual Analog Scale
13%
Diacerein
11%
Internal Fixation
11%
Clavicle
11%
Disabilities of the Arm, Shoulder and Hand (Score)
11%
Misoprostol
11%
Proton-Pump Inhibitor
11%
Adverse Event
9%
Intraarticular Fracture
6%
Injury
6%
Constructive Feedback
5%
Chondroitin Sulfate
5%
Chondroitin
5%
Glucosamine Sulfate
5%
Clinician
5%
Glucosamine
5%
Prescribing Drug
5%
Attitude
5%
Anodyne
5%
Pharmacology, Toxicology and Pharmaceutical Science
Non-Steroidal Anti-Inflammatory Drug
67%
Cross-Sectional Study
50%
Osteoarthritis
33%
Clavicle Fracture
33%
Heavy Metal
33%
Health Status
33%
Paracetamol
22%
Respiratory Tract Disease
16%
Diptera
16%
Deterioration
16%
Ground Water
16%
Drug Utilization
13%
Misoprostol
11%
Diacerein
11%
Proton Pump Inhibitor
11%
Adverse Event
9%
Analgesic Agent
5%
Glucosamine Sulfate
5%
Chondroitin Sulfate
5%
Chondroitin
5%
Glucosamine
5%
Prescribing Drug
5%
